C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 233/54 (2006.01) A61K 31/4164 (2006.01) A61K 31/4192 (2006.01) A61P 35/00 (2006.01) C07C 211/19 (2006.01) C07D 249/04 (2006.01)
Patent
CA 2532078
Compounds of the formula (I); and pharmaceutically acceptable salts thereof, wherein n1, n2, n3, n4, G 1,Q1, Z, R1, R2, R3, R4a, R4b, R5a, and R5b are defined herein, inhibit the cytochrome P450RAI enzyme and are useful for the treatment and/or prevention of various diseases and conditions which respond to treatment by retinoids and by naturally occurring retinoic acid.
L'invention concerne des composés de formule (I) et des sels pharmaceutiquement acceptables de ces composés. Dans ladite formule, n1, n2, n3, n4, G?1¿, Q?1¿, Z, R?1¿, R?2¿, R?3¿, R?4a¿, R?4b¿, R?5a¿ et R?5b¿ sont tels que définis dans la description. Lesdits composés inhibent l'enzyme cytochrome P450RAI et sont utiles pour traiter et/ou prévenir divers états et maladies qui réagissent au traitement par les rétinoïdes et par l'acide rétinoïque d'origine naturelle.
Beck Patricia Anne
Castelhano Arlindo Lucas
Cesario Cara
Mulvihill Mark
Nigro Anthony
Cassan Maclean
Osi Pharmaceuticals Inc.
LandOfFree
Naphthylene derivatives as cytochrome p450 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthylene derivatives as cytochrome p450 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthylene derivatives as cytochrome p450 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1789798